...
首页> 外文期刊>Medicine. >Safety issues related to the electronic cross-matching of blood in mainland China: A prospective cohort study involving cross-matching of 40,228 blood samples
【24h】

Safety issues related to the electronic cross-matching of blood in mainland China: A prospective cohort study involving cross-matching of 40,228 blood samples

机译:与中国大陆电子交叉匹配有关的安全问题:涉及40,228血样品交叉匹配的前瞻性队列研究

获取原文
           

摘要

Although the electronic cross-matching of blood has been widely applied in some developed countries and regions, concern over the risk of undetected red blood cell (RBC) antibodies has limited its application in mainland China. This study was performed to explore the missed detection rate of RBC antibodies in a Chinese population from 2011 to 2016. If the results of 2 consecutive tests of ABO/RhD blood group identification were consistent and antibody screening results were negative, electronic cross-matching of the blood was performed. In addition, traditional serological cross-matching of blood (polybrene method) and a parallel experiment for electronic cross-matching of blood were performed to analyze the missed detection of unexpected RBC antibodies in blood donors and recipients. Using the polybrene method, 40,228 blood samples were tested by parallel traditional serological cross-matching of blood; among these samples, blood compatibility was found in 40,222 cases, primary incompatibility (incompatibility of the donor's erythrocytes with the recipient's serum) was found in 6 cases, and no secondary incompatibility was found. Identification of antibody specificity was performed using panel cells, and all unexpected RBC antibodies were confirmed as anti-Mur alloantibodies in the MNS system. Further improvements in the erythrocyte antigenic spectrum , especially the Mur antigen in Asian populations, are expected to ensure the safety of implementing electronic cross-matching in China.
机译:虽然血液的电子交叉匹配已被广泛应用于一些发达国家和地区,但对未检测到的红细胞(RBC)抗体的风险有所关注其在中国大陆的应用。本研究进行了2011年至2016年中国人口中RBC抗体的错过检测率。如果ABO / RHD血液组鉴定的2个连续试验是一致的,并且抗体筛查结果是负的,电子交叉匹配进行血液。此外,进行了血液(聚酶法)的传统血清学交叉匹配和用于血液的电子交叉匹配的并行实验,以分析献血者和受体中意外RBC抗体的错过检测。采用聚酶法,通过平行传统的血液交叉匹配来测试40,228个血样;在这些样品中,在40,222例中发现血液相容性,在6例中发现了初级不相容性(与受体的血清的供体的红细胞的不相容性)发现,未发现二次不相容性。使用面板细胞进行鉴定抗体特异性,并在MNS系统中证实所有意外的RBC抗体被证实为抗MURALOALIBIADIES。预计红细胞抗原谱,尤其是亚洲群体中的Mur抗原的进一步改善,以确保在中国实施电子交叉匹配的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号